Truist Financial
NRXP icon

Truist Financial’s NRX Pharmaceuticals NRXP Stock Holding History

Truist Financial’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.8K Buy
+20,000
New +$66.1K ﹤0.01% 2852

Other funds holding NRXP

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
OWMIAS
One Wealth Management Investment & Advisory Services Miami Beach, Florida $95.3M AUM 25.31% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.99% 1-Year Est. Return

Truist Financial's NRXP Position: Q2 2026 in Review

Truist Financial opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 20,000 shares worth $81.8K. The stake represents ﹤0.01% of the portfolio and ranks #2852 among its holdings.

9 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Truist Financial held 20,000 shares of NRX Pharmaceuticals worth $81.8K as of Q2 2026.
  • NRX Pharmaceuticals was a new Truist Financial position in Q2 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2852 holding.
  • 9 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.